| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/27/2011 | EP2313397A1 Cyclohexyloxy-substituted heterocyclics, medicines containing these compounds and method for the production thereof |
| 04/27/2011 | EP2313395A1 Pyridone and pyridazone analogues as gpr119 modulators |
| 04/27/2011 | EP2313376A2 Substituted 1-benzyl-cinnolin-4(1h)-one derivatives, preparation thereof, and therapeutic use thereof |
| 04/27/2011 | EP2313369A2 2-methylene-(20e)-20(22)-dehydro-19-nor-vitamin d analogs |
| 04/27/2011 | EP2313368A2 2-methylene-(17z)-17(20)-dehydro-19,21-dinor-vitamin d analogs |
| 04/27/2011 | EP2313367A2 2-methylene-19,26-dinor-(20r,22e,25r)-vitamin d analogs |
| 04/27/2011 | EP2313363A2 Lipid compounds for supression of tumorigenesis |
| 04/27/2011 | EP2313111A1 Toll-like receptor agonist formulations and their use |
| 04/27/2011 | EP2313097A2 Therapeutic combination comprising an aurora kinase inhibitor and antiproliferative agents |
| 04/27/2011 | EP2313095A2 Methods and products for treating proliferative diseases |
| 04/27/2011 | EP2313091A1 Pharmaceutical compositions comprising ret inhibitors and methods for the treatment of cancer |
| 04/27/2011 | EP2312948A1 5-quinolinone and imidazopyridine compounds and use thereof |
| 04/27/2011 | EP2090575B1 Processes and intermediates for the preparation of N4-phenyl-quinazoline-4-amine derivatives |
| 04/27/2011 | EP2029566B1 Novel serotonin reuptake inhibitors as drugs having peripheral-system-restricted activity |
| 04/27/2011 | EP1951724B1 FUSED BICYCLIC mTOR INHIBITORS |
| 04/27/2011 | EP1824832B1 Aryl-substituted benzimidazole and imidazopyridine ethers as anti-cancer agents |
| 04/27/2011 | EP1809330B1 Compositions for reducing toxicity of cisplatin, carboplatin, and oxaliplatin |
| 04/27/2011 | EP1589998B1 IL-27 and IL-2 for use in the treatment of cancer |
| 04/27/2011 | EP1585540B1 Medicament and use thereof for tumor therapy |
| 04/27/2011 | EP1532174B1 Anti-igf-i receptor antibody |
| 04/27/2011 | EP1521746B1 Quinazolinone modulators of nuclear receptors |
| 04/27/2011 | EP1477175B1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient |
| 04/27/2011 | EP1467967B1 Compounds for modulating cell proliferation |
| 04/27/2011 | EP1432446B1 Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation |
| 04/27/2011 | EP1317470B1 Antisense insulin-like growth factor binding protein (igfbp)-2-oligodeoxynucleotides for prostate tumor therapy |
| 04/27/2011 | EP1272633B1 Compositions and methods for dendritic cell-based immunotherapy |
| 04/27/2011 | EP1272617B1 Prostate cell lines and their use |
| 04/27/2011 | EP1253966B1 Substances and agents for positively influencing collagen |
| 04/27/2011 | EP1197218B1 Algae protein polysaccharide extraction and use thereof |
| 04/27/2011 | EP1177796B1 Medicament for prevention or therapeutic treatment of liver disease |
| 04/27/2011 | EP1118660B1 Enzyme producing plasma protein fragment having effect of inhibiting cancer metastasis and plasma protein fragment fragmented by the enzyme |
| 04/27/2011 | EP0934307B1 Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase |
| 04/27/2011 | CN1893925B In vivo targeting of dendritic cells |
| 04/27/2011 | CN1813819B Hedgehog hydnum fruiting body or hyphostroma, culture extract, formulation and preparing method |
| 04/27/2011 | CN1639317B Probiotic lactobacillus salivarius strains |
| 04/27/2011 | CN102037123A Compositions and use of epas1 inhibitors |
| 04/27/2011 | CN102037058A Docetaxel polymer derivative, method for producing same and use of same |
| 04/27/2011 | CN102037015A Inhibition of angiogenesis |
| 04/27/2011 | CN102037005A New optically pure compounds for improved therapeutic efficiency |
| 04/27/2011 | CN102036995A Triazine compounds as P13 kinase and mTOR inhibitors |
| 04/27/2011 | CN102036990A Novel tyrosine kinase inhibitors |
| 04/27/2011 | CN102036989A Polysubstituted derivatives of 6-heteroaryl-imidazo[l,2-a] pyridines, and preparation and therapeutic use thereof |
| 04/27/2011 | CN102036988A Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[l,2-a] pyridines, and preparation and therapeutic use thereof |
| 04/27/2011 | CN102036987A Polysubstituted derivatives of 2-heteroaryl-6-phenyl-imidazo[l,2- a] pyridines, and preparation and therapeutic use thereof |
| 04/27/2011 | CN102036978A Novel thiophenediamine derivative having urea structure |
| 04/27/2011 | CN102036963A Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors |
| 04/27/2011 | CN102036962A Combined use of angiogenesis inhibitor and taxane |
| 04/27/2011 | CN102036959A Polysubstituted 2-aryl-6-phenyl-imidazo[l,2-a] pyridine derivatives, and preparation and therapeutic use thereof |
| 04/27/2011 | CN102036955A Hydroxamate-based inhibitors of deacetylases b |
| 04/27/2011 | CN102036936A Novel [F-18]-labelled l-glutamic acid and l-glutamine derivatives (II), use thereof and method for their production |
| 04/27/2011 | CN102036710A A magnetic breather pump and a method for treating a brain tumor using the same |
| 04/27/2011 | CN102036684A RGD-(bacterio)chlorophyll conjugates for photodynamic therapy and imaging of necrotic tumors |
| 04/27/2011 | CN102036683A Cytotoxic composition |
| 04/27/2011 | CN102036680A Methods of using corticotropin-releasing factor for the treatment of cancer |
| 04/27/2011 | CN102036677A Heat shock protein GP96 vaccination and methods of using same |
| 04/27/2011 | CN102036672A Antitumoral terpenoid pharmaceutical composition 'ABISILIN' exhibiting angiogenesis-inhibiting action |
| 04/27/2011 | CN102036660A Combinations of an anti-HER2 antibody-drug conjugate and chemotherapeutic agents, and methods of use |
| 04/27/2011 | CN102031310A Application of miRNA-195/497 compounds jointly as breast cancer markers |
| 04/27/2011 | CN102031309A Application of miRNA-34c compound as brain glioma marker |
| 04/27/2011 | CN102031308A Application of miRNA-29a compound as brain glioma marker |
| 04/27/2011 | CN102031278A Method for enzymatic synthesis of trehalose unsaturated fatty acid diester in organic phase |
| 04/27/2011 | CN102031256A Human miR-485-5p antisense nucleic acid and application thereof |
| 04/27/2011 | CN102031255A Antisense nucleic acid of human miR-223 and applications of antisense nucleic acid |
| 04/27/2011 | CN102031254A Human miR-150 antisense nucleic acid and application thereof |
| 04/27/2011 | CN102030829A Anti-melanoma cytotoxic lymphocyte (CTL) multi-epitope peptide and application thereof |
| 04/27/2011 | CN102030827A Anti-HER2 monoclonal antibody with high affinity |
| 04/27/2011 | CN102030826A High-affinity CD20-resistance monoclonal antibody |
| 04/27/2011 | CN102030824A Monoclonal antibody of hepatitis B virus X protein and use thereof |
| 04/27/2011 | CN102030822A New human cell factor VSTM1-v2 and application thereof |
| 04/27/2011 | CN102030813A Preparation method and application of yellow ginger zingiberensis saponin having high-efficiency anti-cancer activity |
| 04/27/2011 | CN102030812A Timosaponin A-III serving as medicinal active ingredient with angiogenesis resistance |
| 04/27/2011 | CN102030805A Theasapogenol derivative with anti-tumour activity and preparing method and application thereof |
| 04/27/2011 | CN102030800A Abies holophylla triterpenoid compound, extraction separation thereof and application thereof |
| 04/27/2011 | CN102030796A Several cardiac glycoside compounds separated from rosebay and applications thereof |
| 04/27/2011 | CN102030765A Ether-linked porphyrin dimer salt and preparation method thereof |
| 04/27/2011 | CN102030759A Thienopyridine derivative, and preparation method and application thereof |
| 04/27/2011 | CN102030756A 6,7-methylene-dioxy-1,2,3,4-tetrahydroisoquinoline derivative and preparation method and application thereof |
| 04/27/2011 | CN102030754A Non-viral vector, and preparation method and application thereof |
| 04/27/2011 | CN102030753A Prenylated indole alkaloids and preparation method and application thereof |
| 04/27/2011 | CN102030750A Novel tetrahydro-1H-pyrido [4,3-b] indole derivatives as CB1' receptor ligands |
| 04/27/2011 | CN102030749A Novel process and formulations |
| 04/27/2011 | CN102030742A 4-(substituent phenylamino group) quinazoline derivatives used as tyrosine kinase inhibitor |
| 04/27/2011 | CN102030741A Halogenated pyrrole-substituted 2-indolinone salt and preparation method and application thereof |
| 04/27/2011 | CN102030704A 4-(4-aminobenzene-thio)-2-(carbamoymethyl) pyridine derivative as well as preparation method and application thereof |
| 04/27/2011 | CN102030700A Benzamide carboxylic acid compound as well as manufacturing method and medicinal application thereof |
| 04/27/2011 | CN102028958A Composite tumor gene vaccine taking bacterial nano magnetosome as carrier and preparation method thereof |
| 04/27/2011 | CN102028957A Application of BTG2 (B cell translocation gene 2) in preparing radiation sensitizing agent |
| 04/27/2011 | CN102028956A Application of BTG2 (B Cell Translocation Gene 2) in preparing medicament for inhibiting cancer transfer |
| 04/27/2011 | CN102028955A Novel targeting compound for tumor gene interference |
| 04/27/2011 | CN102028953A Compositions and methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells |
| 04/27/2011 | CN102028952A Galactan sulfate 5-fluorouracil compound and preparation and application thereof |
| 04/27/2011 | CN102028951A RGDfK-modified oridonin polylactic acid medicament-carrying nanoparticles and preparation method thereof |
| 04/27/2011 | CN102028948A Manganoporphyrin-alkylating agent combined medicine for treating tumors |
| 04/27/2011 | CN102028934A Taxol complex preparation drug |
| 04/27/2011 | CN102028924A Medicinal composition for late gastric cancer |
| 04/27/2011 | CN102028871A Plaster for treating digestive tract cancer |
| 04/27/2011 | CN102028861A New liver and kidney nourishing decoction preparation (novel medicament delivery system) and preparation method thereof |
| 04/27/2011 | CN102028831A Traditional Chinese medicine composition for treating tumors or cancers and preparation method thereof |
| 04/27/2011 | CN102028820A Externally-applied medicament for radical treatment of all types of cancers and difficult and complicated diseases |
| 04/27/2011 | CN102028757A Processing method of mulberry composite extract |